Loss of p53 gene function, which occurs in most colon cancer cells, has been shown to abolish the apoptotic response to 5-fluorouracil (5-FU). To identify genes downstream of p53 that might mediate these effects, we assessed global patterns of gene expression following 5-FU treatment of isogenic cells differing only in their p53 status. The gene encoding mitochondrial ferredoxin reductase (protein, FR; gene, FDXR) was one of the few genes significantly induced by p53 after 5-FU treatment. The FR protein was localized to mitochondria and suppressed the growth of colon cancer cells when over-expressed. Targeted disruption of the FDXR gene in human colon cancer cells showed that it was essential for viability, and partial disruption of the gene resulted in decreased sensitivity to 5-FU-induced apoptosis. These data, coupled with the effects of pharmacologic inhibitors of reactive oxygen species, indicate that FR contributes to p53-mediated apoptosis through the generation of oxidative stress in mitochondria.5-fluorouracil (5-FU) has been in clinical use for several decades and is still the most effective adjuvant therapy for patients with colon cancer. Metabolically, it acts by blocking the enzyme thymidylate synthase and by inhibiting both RNA and DNA synthesis. Like most chemotherapeutic agents, 5-FU induces marked apoptosis in sensitive cells. However, the molecular mechanisms underlying this apoptosis are only beginning to be elucidated.Several studies have suggested a correlation between inactivation of p53 and resistance to 5-FU, both in patients and in experimental systems 1,2 . For example, a profound resistance to 5-FU-induced apoptosis was observed in a human colon cancer cell line with a targeted disruption of the p53 gene (Trp53) 3 . Such observations support a genetic basis for 5-FU chemosensitivity and indicate that isogenic cells differing only in p53 status represent a useful system for studying chemosensitivity in vitro.© 2001 Nature Publishing Group Correspondence should be addressed to B.V.; vogelbe@welch.jhu.edu. Supplementary information is available on the Nature Medicine website (http://medicine.nature.com/supplementary_info/).
NIH Public Access
NIH-PA Author ManuscriptThe mechanisms through which p53 induces apoptosis are the focus of much current research [4][5][6][7] . Several studies have implicated mitochondria-derived reactive oxygen species (ROS) in the process [8][9][10][11] . Though pro-apoptotic members of the Bcl-2 family of proteins have been shown to be induced by p53 and affect mitochondrial permeability, the molecular mechanisms responsible for the formation of mitochondrial ROS remain unclear 12,13 .In an effort to gain further insight into this process, we examined global patterns of gene expression using the serial analysis of gene expression (SAGE) approach 14 . We were particularly interested in finding p53-induced genes that encode mitochondrial proteins with the potential to directly stimulate ROS production. Here we identify mammalian ferredoxin reductase (FR) ...